{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:57:32Z","timestamp":1783468652719,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P32699"],"award-info":[{"award-number":["P32699"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejpn.2024.04.011","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T06:20:49Z","timestamp":1713939649000},"page":"86-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1777-9378","authenticated-orcid":false,"given":"Alina","family":"Peternell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3825-5749","authenticated-orcid":false,"given":"Markus","family":"Breu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-9795","authenticated-orcid":false,"given":"Martin","family":"Preisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Eisenk\u00f6lbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-1402","authenticated-orcid":false,"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rost\u00e1sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4471-8324","authenticated-orcid":false,"given":"Matthias","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2024.04.011_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"E.U. paediatric MOG consortium consensus: Part 1 \u2013 classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.011_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.ejpn.2024.04.011_bib3","first-page":"1929","article-title":"Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study","volume":"259","author":"Ketelslegers","year":"2012","journal-title":"J.\u00a0Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.011_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.spen.2017.08.007","article-title":"The spectrum of inflammatory acquired demyelinating syndromes in children","volume":"24","author":"Neuteboom","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2024.04.011_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.ejpn.2024.04.011_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","article-title":"Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"75","author":"Hacohen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.011_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","article-title":"Incidence of acquired demyelination of the CNS in Canadian children","volume":"72","author":"Banwell","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ejpn.2024.04.011_bib8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort","volume":"21","author":"Ketelslegers","year":"2015","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.011_bib9","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1212\/NXI.0000000000000432","article-title":"Characterization of lymphopenia in patients with MS treated with dimethyl fumarate and fingolimod","volume":"5","author":"Nakhaei-Nejad","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejpn.2024.04.011_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.816721","article-title":"The alteration of circulating lymphocyte subsets during tacrolimus therapy in neuromyelitis optica spectrum disorder and its correlation with clinical outcomes","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2024.04.011_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejpn.2020.10.005","article-title":"E.U. paediatric MOG consortium consensus: Part 5 \u2013 treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2024.04.011_bib12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00296-019-04274-z","volume":"39","author":"Jaszczura","year":"2019","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.011_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.abd.2019.05.002","article-title":"Evaluation of monocyte to high-density lipoprotein ratio, lymphocytes, monocytes, and platelets in psoriasis","volume":"95","author":"Akta\u015f Karabay","year":"2020","journal-title":"An. Bras. Dermatol."},{"issue":"4","key":"10.1016\/j.ejpn.2024.04.011_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.15537\/smj.2016.4.14768","article-title":"Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases. Perspectives and therapeutic aspects","volume":"37","author":"Harifi","year":"2016","journal-title":"Saudi Med. J."},{"issue":"12","key":"10.1016\/j.ejpn.2024.04.011_bib15","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/art.24316","article-title":"C-reactive protein and systemic lupus erythematosus","volume":"59","author":"Gaitonde","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.ejpn.2024.04.011_bib16","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1590\/0004-282X20160132","article-title":"Analysis of the albumin level, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in Guillain-Barr\u00e9 syndrome","volume":"74","author":"Ozdemir","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"issue":"10","key":"10.1016\/j.ejpn.2024.04.011_bib17","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10072-017-3068-5","article-title":"Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD","volume":"38","author":"Lin","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejpn.2024.04.011_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.msard.2017.10.009","article-title":"The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis","volume":"18","author":"Bisgaard","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.011_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.17219\/acem\/83588","article-title":"Interactions between platelets and leukocytes in pathogenesis of multiple sclerosis","volume":"28","author":"Dziedzic","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.ejpn.2024.04.011_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2018.03.016","article-title":"Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis","volume":"319","author":"Akaishi","year":"2018","journal-title":"J.\u00a0Neuroimmunol."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.011_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-019-1245-2","article-title":"The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis","volume":"19","author":"Hemond","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ejpn.2024.04.011_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102345","article-title":"Neutrophil-to-lymphocyte ratio correlates with disease activity in myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) in children","volume":"45","author":"Benetou","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.011_bib23","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1038\/s41598-023-33827-3","article-title":"White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"13","author":"Akaishi","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.011_bib24","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.ejpn.2024.04.011_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010455","article-title":"Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica","volume":"5","author":"Mader","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.011_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11910-003-0086-x","article-title":"Postinfectious encephalomyelitis","volume":"3","author":"Wingerchuk","year":"2003","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ejpn.2024.04.011_bib27","series-title":"StatPearls [Internet]","article-title":"Leukocytosis","author":"Mank","year":"2023"},{"issue":"16","key":"10.1016\/j.ejpn.2024.04.011_bib28","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1097\/CM9.0000000000000854","article-title":"Age-dependent changes of total and differential white blood cell counts in children","volume":"133","author":"Li","year":"2020","journal-title":"Chin Med J (Engl)."},{"key":"10.1016\/j.ejpn.2024.04.011_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","article-title":"Inflammatory demyelinating diseases of the central nervous system","volume":"145","author":"H\u00f6ftberger","year":"2017","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.011_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejpn.2006.11.007","article-title":"Acute disseminated encephalomyelitis cohort study: prognostic factors for relapse","volume":"11","author":"Mikaeloff","year":"2007","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2024.04.011_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2013.03.021","article-title":"Acute disseminated encephalomyelitis in children and adolescents: a single center experience","volume":"49","author":"Erol","year":"2013","journal-title":"Pediatr. Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2024.04.011_bib32","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1212\/WNL.59.8.1224","article-title":"Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients","volume":"59","author":"Tenembaum","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2024.04.011_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104796","article-title":"Novel index, neutrophil percentage (%) is a useful marker for disease activity in MOG antibody-associated disease","volume":"76","author":"Baek","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"10.1016\/j.ejpn.2024.04.011_bib34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1373\/clinchem.2015.239731","article-title":"Age- and sex-specific dynamics in 22 hematologic and biochemical analytes from birth to adolescence","volume":"61","author":"Zierk","year":"2015","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.ejpn.2024.04.011_bib35","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/v13091876","article-title":"Lymphopenia caused by virus infections and the mechanisms beyond","volume":"13","author":"Guo","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ejpn.2024.04.011_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar4325","article-title":"Role of neutrophils in systemic autoimmune diseases","volume":"15","author":"Kaplan","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejpn.2024.04.011_bib37","series-title":"StatPearls [Internet]","article-title":"Neutrophilia","author":"Tahir","year":"2023"},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.011_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-017-2763-0","article-title":"Neutrophils in viral infection","volume":"371","author":"Naumenko","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.011_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2012.01.013","article-title":"The role of neutrophils in autoimmune diseases","volume":"143","author":"N\u00e9meth","year":"2012","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.ejpn.2024.04.011_bib40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0002-9343(81)90363-6","article-title":"Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis","volume":"71","author":"Shoenfeld","year":"1981","journal-title":"Am. J. Med."},{"issue":"21","key":"10.1016\/j.ejpn.2024.04.011_bib41","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.12998\/wjcc.v10.i21.7187","article-title":"Effects of glucocorticoids on leukocytes: genomic and non-genomic mechanisms","volume":"10","author":"Jia","year":"2022","journal-title":"World J Clin Cases"},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.011_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2024.04.011_bib43","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000837","article-title":"Treatment and outcome of aquaporin-4 antibody-positive NMOSD: a multinational pediatric study","volume":"7","author":"Paolilo","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.ejpn.2024.04.011_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MEG.0b013e32834233a2","article-title":"Natural history of azathioprine-associated lymphopenia in inflammatory bowel disease patients: a prospective observational study","volume":"23","author":"Al","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.ejpn.2024.04.011_bib45","first-page":"429","article-title":"The effects of azathioprine and 6 MP on immunity","volume":"1","author":"Winkelstein","year":"1979","journal-title":"J\u00a0Immunopharmacol"},{"issue":"9","key":"10.1016\/j.ejpn.2024.04.011_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.362","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","volume":"5","author":"Garg","year":"2015","journal-title":"Brain Behav"},{"issue":"Suppl 6","key":"10.1016\/j.ejpn.2024.04.011_bib47","doi-asserted-by":"crossref","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","article-title":"Multiple sclerosis, a treatable disease","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejpn.2024.04.011_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.yapd.2019.03.003","article-title":"Pediatric multiple sclerosis: a review","volume":"66","author":"Langille","year":"2019","journal-title":"Adv. Pediatr."},{"issue":"1","key":"10.1016\/j.ejpn.2024.04.011_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti\u2013myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejpn.2024.04.011_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejpn.2020.10.007","article-title":"E.U. paediatric MOG consortium consensus: Part 4 \u2013 outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"10","key":"10.1016\/j.ejpn.2024.04.011_bib51","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1002\/ajh.25904","article-title":"Pediatric hematology normal ranges derived from pediatric primary care patients","volume":"95","author":"Staffa","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.04.011_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ajcp\/aqaa057","article-title":"CALIPER hematology reference standards (II)","volume":"154","author":"Higgins","year":"2020","journal-title":"Am. J. Clin. Pathol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379824000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:33:02Z","timestamp":1726360382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379824000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":52,"alternative-id":["S1090379824000576"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.04.011","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}